Dose–response relationships of normal blood lipid levels in metabolic and endocrine diseases: mechanistic similarities, differences, and functional insights - Summary - MDSpire
Advertisement
Dose–response relationships of normal blood lipid levels in metabolic and endocrine diseases: mechanistic similarities, differences, and functional insights
To systematically summarize the associations between lipid components within the normal range and the risk of major metabolic and endocrine diseases, with a strong emphasis on dose-response relationships and their underlying mechanisms.
Key Findings:
Even within the normal lipid range, variations can influence disease risk, particularly in conditions like diabetes and cardiovascular diseases.
Traditional binary health-disease distinctions may overlook continuous dose-response patterns, complicating risk assessments.
Subtle lipid fluctuations can induce early pathological processes such as atherosclerosis and insulin resistance, emphasizing the need for continuous monitoring.
Interpretation:
The findings suggest that normal lipid levels may not adequately reflect an individual's metabolic risk, indicating a need for refined risk assessment strategies that incorporate continuous monitoring and individualized approaches.
Limitations:
The review may not encompass all metabolic and endocrine disorders, potentially limiting its applicability.
Variability in individual physiological characteristics and environmental factors complicates the interpretation of lipid levels, and potential biases in the reviewed studies should be acknowledged.
Conclusion:
Future research should focus on understanding dose-response relationships in lipid management to enhance early disease identification and individualized risk management, particularly in high-risk populations.
Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.
